Association between serum ferritin level and fibromyalgia syndrome

European Journal of Clinical Nutrition

Volumn 64, Issue 3, 2010, Pages 308-312

  Ortancil, O ^a   Sanli, A ^a   Eryuksel, R ^b   Basaran, A ^a   Ankarali, H ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b Zonguldak Ataturk State Hospital   (Turkey)

Author keywords

Ferritin; Fibromyalgia; Iron deficiency; Pathophysiology

Indexed keywords

CYANOCOBALAMIN; FERRITIN; FOLIC ACID;

ADULT; AGE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; FIBROMYALGIA; FOLIC ACID BLOOD LEVEL; HUMAN; PREVALENCE; RISK FACTOR; SMOKING; VITAMIN BLOOD LEVEL;

ANEMIA, IRON-DEFICIENCY; BIOGENIC AMINES; CASE-CONTROL STUDIES; DOPAMINE; FEMALE; FERRITINS; FIBROMYALGIA; FOLIC ACID; HUMANS; IRON; LOGISTIC MODELS; MIDDLE AGED; RISK FACTORS; SEROTONIN; VITAMIN B 12;

EID: 77949270734     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2009.149     Document Type: Article

References (29)

1. Abeles AM, Pillinger MH, Solitar BM, Abeles M (2007). Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 1, 726-734.
2. Allen R (2004). Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 1, 385-391.
3. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003). Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 1, 101-119.
4. Bazzichi L, Giannaccini G, Betti L, Mascia G, Fabbrini L, Italiani P et al. (2006). Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther 8, R99.
5. Beard JL, Connor JR, Jones BC (1993). Iron in the brain. Nutr Rev 1, 157-170.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 1, 561-571.
7. Burckhardt CS, Clark SR, Bennett RM (1991). The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1, 728-733.
8. DeMaeyer E, Adiels-Tegman M (1985). The prevalence of anaemia in the world. World Health Stat Q 1, 302-316.
9. Dowling P, Klinker F, Amaya F, Paulus W, Liebetanz D (2009). Iron-deficiency sensitizes mice to acute pain stimuli and formalin-induced nociception. J Nutr 1, 2087-2092.
10. Gamaldo CE, Earley CJ (2006). Restless legs syndrome: a clinical update. Chest 1, 1596-1604.
11. Gerwin R (2005). A review of myofascial pain and fibromyalgia - factors that promote their persistence. Acupunct Med 1, 121-134.
12. Hisli N (1988). The reliability and validity study of the Beck Depression Inventory in a Turkish sample. Turk J Psychol (in Turkish) 1, 118-122.
13. Kathlen ML, Escott-Stump S (2004). Krauses Food Nutrition and Diet Therapy, 10th edn Chapman and Hall: Philadelphia, PA.
14. Legangneux E, Mora JJ, Spreux-Varoquaux O, Thorin I, Herrou M, Alvado G et al. (2001). Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxford) 1, 290-296.
15. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J (2005). CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 1, 43-47.
16. Moldofsky H, Warsh JJ (1978). Plasma tryptophan and musculoske-letal pain in non-articular rheumatism ('fibrositis syndrome'). Pain 1, 65-71.
17. Morse AC, Beard JL, Jones BC (1999). A genetic developmental model of iron deficiency: biological aspects. Proc Soc Exp Biol Med 1, 147-152.
18. Neeck G (2002). Pathogenic mechanisms of fibromyalgia. Ageing Res Rev 1, 243-255.
19. O'Keeffe ST, Gavin K, Lavan JN (1994). Iron status and restless legs syndrome in the elderly. Age Ageing 1, 200-203.
20. Otto M, Bach FW, Jensen TS, Brosen K, Sindrup SH (2008). Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial. Pain 1, 275-283.
21. Pamuk GE, Pamuk ON, Set T, Harmandar O, Yesil N (2008). An increased prevalence of fibromyalgia in iron deficiency anemia and thalassemia minor and associated factors. Clin Rheumatol 1, 1103-1108.
22. Russell IJ, Vaeroy H, Javors M, Nyberg F (1992). Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1, 550-556.
23. Sarmer S, Ergin S, Yavuzer G (2000). The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 1, 9-12.
24. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP (1998). Iron and the restless legs syndrome. Sleep 1, 371-377.
25. Vahdat Shariatpanaahi M, Vahdat Shariatpanaahi Z, Moshtaaghi M, Shahbaazi SH, Abadi A (2007). The relationship between depression and serum ferritin level. Eur J Clin Nutr 1, 532-535.
26. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al. (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1, 160-172.
27. Wood PB, Patterson II JC, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL (2007a). Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 1, 51-58.
28. Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA et al. (2007b). Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 1, 3576-3582.
29. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992). Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 1, 90-94.